Authors

Camille N. Abboud, MD, Washington University School of Medicine

Cancer Care

Cancer Care: A Webinar Without Walls Lecture Series

CancerControl Alberta

Candace Haddox, MD

Latest:

Perspectives on the Hematology-Oncology Fellowship Journey

Candace Haddox, MD, and Narjust Duma, MD, address the uncertainty, the victories, and the defeats common in oncology fellowship programs.

Carey Anders, MD

Latest:

Dr. Anders on Navigating the Treatment Landscape of Metastatic TNBC

Carey K. Anders, MD, discusses navigating the treatment landscape of metastatic triple-negative breast cancer.

Carey K. Anders, MD, Duke Cancer Institute

Latest:

Dr. Anders on the Lessons Learned From the OlympiA Trial in BRCA-Mutated Breast Cancer

Carey K. Anders, MD, discusses lessons learned from the phase 3 OlympiA trial in BRCA-mutated breast cancer.

Carina Dolan, PharmD, BCOP

Latest:

Biosimilar Uptake in Oncology Faces Many Hurdles

Carina Dolan, PharmD, BCOP, discusses the factors that impact the successful uptake of biosimilars in the practice of oncology.

Carl Maltese, MD

Latest:

Resection and Reconstruction of a Solitary Sternal Metastasis After Mastectomy for Breast Cancer: A Case Report and Review of the Literature

In May 2005, a 25-year-old female presented to her primary care physician complaining of a newly palpable breast mass that had grown to several centimeters over the course of a few months.

Carl Olsson, MD

Latest:

Dr. Olsson on Differences Between LHRH Agonists and Antagonists in Prostate Cancer

Carl Olsson, MD, Integrated Medical Professionals, compares the efficacy of LHRH agonists with antagonists, which are commonly used to treat patients with prostate cancer.

Carla Casulo, MD

Carla Casulo, MD, is an associate professor of medicine and assistant director of Cancer Research Training and Education at the Wilmot Cancer Institute in Rochester, New York.

Latest:

Voices in Lymphoma: Women Shaping the Future of Care

Clémentine Sarkozy, MD, PhD, and Carla Casulo, MD, detail the evolution of lymphoma management strategies.

Carla Casulo, MD, University of Rochester Medical Center

Carla Casulo, MD, University of Rochester, Wilmot Cancer Institute

Carlito B. Lebrilla, PhD

Latest:

Glycans Emerge as Promising Biomarkers for Early Detection of Many Cancer Types

For many years, we in the medical and research communities have tried to use proteins and DNA fragments as disease markers to find cancer early.

Carlos Arteaga

Latest:

Dr. Arteaga on PI3K Pathway Inhibitors

Carlos Arteaga, MD, assistant director, Clinical Research, director, Breast Cancer program, Vanderbilt-Ingram Cancer Center, discusses the PI3K pathway and the role of therapeutic inhibitors in reducing the progression of breast cancer.

Carlos Arteaga, MD

Latest:

Dr Arteaga on CDK4/6 Inhibitor Resistance in ER+ Breast Cancer

Carlos Arteaga, MD, discusses the resistance to CDK4/6 inhibitors in estrogen receptor–positive breast cancer.

Carlos Becerra, MD

Latest:

Dr. Becerra Discusses Dosing Strategies in CRC

Carlos Becerra, MD, medical oncologist, Texas Oncology, discusses dosing strategies in the treatment of patients with colorectal cancer.

Carlos E. Vargas, MD

Latest:

Dr. Vargas on Research With Proton Therapy in Prostate Cancer

Carlos E. Vargas, MD, discusses research with proton therapy in prostate cancer.

Carlos H. Barcenas, MD

Latest:

Dr. Barcenas on Colestipol in Management of Neratinib Side Effects in HER2+ Breast Cancer

Carlos Barcenas, MD, assistant professor, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses managing neratinib-related side effects with colestipol (Colestid).

Carlos H. Barrios, MD, PUCRS School of Medicine